Meena Sharma

Meena Sharma

Meena Sharma’s practice covers international export controls, sanctions, foreign investment, and anti-corruption. Ms. Sharma counsels companies on US sanctions and export regulations administered by the U.S. State Department’s Directorate of Defense Trade Controls (DDTC), the Commerce Department’s Bureau of Industry and Security (BIS), and the Treasury Department’s Office of Foreign Assets Control (OFAC). She also provides advice to companies on compliance, licensing, and enforcement actions and has assisted companies in conducting internal investigations and filing voluntary self-disclosures with DDTC, BIS, and OFAC.

Subscribe to all posts by Meena Sharma

Another Medical Device Company is Cleared, Coming Off A Long List of Open FCPA-Related Investigations

For over five years, Medtronic, Inc. (Medtronic), a Minnesota-based medical technology company, had been the subject of open investigations by the US Securities and Exchange Commission (SEC) and the US Department of Justice (DOJ) under the US Foreign Corrupt Practices Act (FCPA).  This summer, Medtronic announced, in its annual report filed with the SEC on … Continue Reading

FCPA Enforcement Action Against China-Based Company and Lessons for the Device Industry

The first Foreign Corrupt Practices Act (“FCPA”) enforcement action of the year, which also appears to be the first FCPA-related enforcement action against a China-based company, underscores key areas that are likely to raise corruption issues in markets such as China.  This recent enforcement action also reinforces several lessons which are important for the medical … Continue Reading